Crocs insider plans sale of 10,928 shares

Crocs, Inc. insider filing indicates a planned sale of 10,928 shares of common stock through Morgan Stanley Smith Barney LLC on or about 08/07/2026 on NASDAQ, with an aggregate market value of $1,508,248.20.

Rhea-AI Filing Summary

Crocs, Inc. insider filing indicates a planned sale of 10,928 shares of common stock through Morgan Stanley Smith Barney LLC on or about 08/07/2026 on NASDAQ, with an aggregate market value of $1,508,248.20. The filing notes 47,945,075 shares of common stock outstanding. The shares derive from Performance Stock Units granted in 2021 and 2024 as compensation. Recent sales over the past three months include 32,688 shares sold for $3,860,282.82 by The Rees Family Living Trust and 5,000 shares sold for $538,418.00 by The Rees Family Foundation, Inc.

Key Figures

Shares to be sold: 10,928 shares Aggregate market value: $1,508,248.20 Shares outstanding: 47,945,075 shares +4 more

7 metrics

Shares to be sold 10,928 shares Proposed sale of Crocs common stock around 08/07/2026

Aggregate market value $1,508,248.20 Value of 10,928 Crocs shares proposed for sale

Shares outstanding 47,945,075 shares Crocs common shares outstanding referenced in the filing

PSU grant 2021 5,073 units Performance Stock Units granted on 07/22/2021 as compensation

PSU grant 2024 5,855 units Performance Stock Units granted on 08/17/2024 as compensation

Trust sale 32,688 shares; $3,860,282.82 Sale by The Rees Family Living Trust on 06/05/2026

Foundation sale 5,000 shares; $538,418.00 Sale by The Rees Family Foundation, Inc. on 05/21/2026

Key Terms

Performance Stock Units, aggregate market value, Form 144

3 terms

Performance Stock Units financial

"Common | 07/22/2021 | Performance Stock Units | Issuer"

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

aggregate market value financial

"10928 | 1508248.20 | 47945075 | 08/07/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

Form 144 regulatory

"144: Securities Information Common | Morgan Stanley Smith Barney"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What number of CROX shares are proposed to be sold under this Form 144?

The filing covers a proposed sale of 10,928 shares of Crocs common stock. These shares have an aggregate market value of $1,508,248.20 and are expected to be sold on NASDAQ around 08/07/2026.

What is the aggregate market value of CROX shares in this Form 144 filing?

The proposed sale has an aggregate market value of $1,508,248.20. This value relates to the planned disposition of 10,928 shares of Crocs common stock to be sold on or about 08/07/2026.

How many CROX shares are outstanding as referenced in this Form 144?

The Form 144 references 47,945,075 shares of Crocs common stock outstanding. This figure provides context for the 10,928 shares proposed to be sold and does not represent additional shares being registered or issued.

What prior CROX share sales are disclosed in the past three months?

The Rees Family Living Trust sold 32,688 shares for $3,860,282.82 on 06/05/2026, and The Rees Family Foundation, Inc. sold 5,000 shares for $538,418.00 on 05/21/2026, both involving Crocs common stock.

What is the source of the CROX shares being sold in this Form 144?

The shares come from Performance Stock Units granted as compensation. Grants include PSUs dated 07/22/2021 for 5,073 units and 08/17/2024 for 5,855 units, both issued by Crocs as compensation awards.

Through which broker are the CROX shares planned to be sold?

The proposed sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker is listed at 1 New York Plaza, 8th Floor, New York, NY 10004, with the sale expected on NASDAQ around 08/07/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 05:05 PM Accepted by SEC EDGAR 08/07/2026 - 05:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001609901
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CROCS, INC.
SEC File Number	000-51754
Address of Issuer	500 ELDORADO BOULEVARD BUILDING 5 BROOMFIELD COLORADO 80021
Phone	3038487000
Name of Person for Whose Account the Securities are To Be Sold	THE REES FAMILY LIVING TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10928	1508248.20	47945075	08/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/22/2021	Performance Stock Units	Issuer			5073	07/22/2021	Compensation
Common	08/17/2024	Performance Stock Units	Issuer			5855	08/17/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
THE REES FAMILY LIVING TRUST U/A 500 Eldorado Blvd., Building 5, Broomfield CO 80021	Common	06/05/2026	32688	3860282.82
THE REES FAMILY FOUNDATION, INC. 500 Eldorado Blvd., Building 5, Broomfield CO 80021	Common	05/21/2026	5000	538418.00

144: Remarks and Signature

Remarks
Date of Notice	08/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew Rees, Trustee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)